Leaderboards/Sarcoma Diagnosis and Treatment

Sarcoma Diagnosis and Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Jaleh Fallah
United States Food and Drug Administration
2
Lisa Vermij
Leiden University Medical Center
3
Sara G. Danielli
University Children's Hospital Zurich
4
Peter Peneder
University of Vienna
5
A. G. Muradyan
Ministry of Health of the Russian Federation
6
Xiangyu Chu
Capital Medical University
7
Zebin Tong
Center for Life Sciences
8
Shampavi Sri Haran
Children's Health Queensland Hospital and Health Service
9
Justin W. Magrath
Tulane University
10
Anton Safonov
Memorial Sloan Kettering Cancer Center

Papers

1
Efficacy of Poly(ADP-ribose) Polymerase Inhibitors by Individual Genes in Homologous Recombination Repair Gene-Mutated Metastatic Castration-Resistant Prostate Cancer: A US Food and Drug Administration Pooled Analysis
Journal of Clinical Oncology|2024
74 cit.
2
Publication in Nature Structural & Molecular Biology (2024) [42 citations, W4390587985]
Nature Structural & Molecular Biology|2024
42 cit.
3
Publication in Biomaterials (2024) [42 citations, W4401043579]
Biomaterials|2024
42 cit.
4
Single cell transcriptomic profiling identifies tumor-acquired and therapy-resistant cell states in pediatric rhabdomyosarcoma
Nature Communications|2024
36 cit.
5
FDA Approval Summary: Belzutifan for Patients with Advanced Renal Cell Carcinoma
Clinical Cancer Research|2024
27 cit.
6
Publication in Cancer Research (2024) [18 citations, W4394581726]
Cancer Research|2024
18 cit.
7
Cytoreductive nephrectomy in the era of immune checkpoint inhibitors: a US Food and Drug Administration pooled analysis
JNCI Journal of the National Cancer Institute|2024
12 cit.
8
Equipoise Lost? Trial Conduct Challenges in an Era of Breakthrough Therapies
Journal of Clinical Oncology|2024
9 cit.
9
Publication in Oncogenesis (2024) [8 citations, W4390580509]
Oncogenesis|2024
8 cit.
10
Publication in Communications Biology (2024) [8 citations, W4393951874]
Communications Biology|2024
8 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Yun-Shao Sung
Memorial Sloan Kettering Cancer Center
2
Sarah Chiang
Memorial Sloan Kettering Cancer Center
3
Christina L. Roland
The University of Texas MD Anderson Cancer Center
4
Anne C. Rios
Utrecht University
5
Sandy Beare
King's College London
6
Ryma Benayed
Memorial Sloan Kettering Cancer Center
7
Eleni M. Tomazou
St Anna Children's Hospital
8
J. Todd Auman
University of North Carolina at Chapel Hill
9
Kyle R. Covington
Duke University
10
Ad Gillis
Princess Máxima Center

Papers

1
Uncovering the mode of action of engineered T cells in patient cancer organoids
Nature Biotechnology|2022
212 cit.
2
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Nature Cancer|2024
56 cit.
3
Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients
Annals of Surgical Oncology|2022
54 cit.
4
Molecular-Based Immunohistochemical Algorithm for Uterine Leiomyosarcoma Diagnosis
Modern Pathology|2023
49 cit.
5
BEHAV3D: a 3D live imaging platform for comprehensive analysis of engineered T cell behavior and tumor response
Nature Protocols|2024
30 cit.
6
Expanding the Spectrum of NR4A3 Fusion–Positive Gynecologic Leiomyosarcomas
Modern Pathology|2024
17 cit.
7
An Exploration of Doctor of Physical Therapy Students' Belongingness in Clinical Education: A Validation Study
Journal of Physical Therapy Education|2023
12 cit.
8
Establishing guidelines for sentinel lymph node ultrastaging in endometrial cancer
International Journal of Gynecological Cancer|2024
12 cit.
9
When to ditch the ladder and take the elevator: The Anderson SArcoma Risk of Complications (A‐SARC) score to guide reconstructive decision‐making in extremity soft tissue sarcoma patients
Journal of Surgical Oncology|2024
9 cit.
10
Development of a bioreactor and volumetric bioprinting protocol to enable perfused culture of biofabricated human epithelial mammary ducts and endothelial constructs
Biofabrication|2025
9 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Christopher D.�M. Fletcher
Brigham and Women's Hospital
2
Murray F. Brennan
Memorial Sloan Kettering Cancer Center
3
Cristina R. Antonescu
Memorial Sloan Kettering Cancer Center
4
Marc Ladanyi
Memorial Sloan Kettering Cancer Center
5
Jean‐Yves Blay
Université Claude Bernard Lyon 1
6
Piero Picci
Istituto Ortopedico Rizzoli
7
Samuel Singer
Memorial Sloan Kettering Cancer Center
8
Alessandro Gronchi
Fondazione IRCCS Istituto Nazionale dei Tumori
9
Paolo G. Casali
Fondazione IRCCS Istituto Nazionale dei Tumori
10
Sharon W. Weiss
Tel Aviv University

Papers

1
Comprehensive molecular characterization of gastric adenocarcinoma
Nature|2014
6.5k cit.
2
World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone
Lund University Publications (Lund University)|2002
2.8k cit.
3
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
The Lancet|2006
2.6k cit.
4
Two Hundred Gastrointestinal Stromal Tumors
Annals of Surgery|2000
2.5k cit.
5
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology|2018
1.6k cit.
6
Malignant fibrous histiocytoma.An Analysis of 200 Cases
Cancer|1978
1.5k cit.
7
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
The Lancet|2012
1.4k cit.
8
Epithelioid hemangioendothelioma a vascular tumor often mistaken for a carcinoma
Cancer|1982
1.4k cit.
9
Liver resection for colorectal metastases.
Journal of Clinical Oncology|1997
1.3k cit.
10
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
Journal of Thoracic Oncology|2013
1.3k cit.

Reagents for Sarcoma Diagnosis and Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Agilent/DakoEvidence 63

Anti-Desmin

Cited in 7 papers
#M0760
View Evidence →
Agilent/Dako

Epithelial Membrane Antigen (EMA)

Cited in 6 papers
#M0613
View Evidence →
Cell Signaling Technology

SignalSlide® Phospho-Met (Tyr1234/1235) IHC Controls

Cited in 6 papers
#8118$196
View Evidence →

🌟 All-Time

Most validated

Agilent/Dako

CD 117 (c-Kit, SCF-Receptor)

Cited in 19 papers
#A4502
View Evidence →
Cell Signaling Technology

TRBP2 (D7C8K) Rabbit Monoclonal Antibody

Cited in 10 papers
#62043$161,351
View Evidence →
DSHBEvidence 68

Tumor Protein P53 Peptide 2

Cited in 9 papers
#CPTC-TP53-2
View Evidence →